Canada · Delayed Price · Currency is CAD Exchange Income Earnings Call Transcripts
Fiscal Year 2025
-
Record 2025 results with double-digit growth in revenue, EBITDA, and EPS, driven by strategic acquisitions and robust demand across segments. Balance sheet deleveraged, investment-grade rating achieved, and 2026 guidance raised to upper end of range.
-
Record Q3 results set new highs in revenue, EBITDA, and earnings, driven by the Canadian North acquisition and strong demand across segments. 2026 guidance projects further EBITDA growth, with significant upside potential from contract wins and industry tailwinds. Guidance excludes new acquisitions or major contract wins.
-
Record Q2 results with $720M revenue and strong growth in both aviation and manufacturing segments. Canadian North acquisition and Nunavut contract drive 2025 guidance higher, though forest fires and tariffs present headwinds. Robust liquidity and M&A pipeline support continued expansion.
-
Record Q1 results with revenue up 23% in manufacturing and 4% in A&A, driven by strong demand in environmental access solutions and essential air services. Guidance for 2025 is reaffirmed, with growth expected across segments and a robust M&A pipeline, while Canadian North acquisition and major contract bids remain pending.
Fiscal Year 2024
-
Record Q4 and full-year results were achieved, led by Aerospace & Aviation, with strong growth in Environmental Access Solutions and a major acquisition of Canadian North announced. 2025 guidance remains robust, with proactive risk management and a conservative balance sheet supporting future growth.
-
Record Q3 results with all-time highs in revenue, adjusted EBITDA, and free cash flow, driven by aerospace and aviation. Strategic Spartan acquisition expands U.S. presence, while 2025 guidance reflects continued growth and strong contract momentum.
-
Record Q2 results with revenue of CAD 661M and adjusted EBITDA of CAD 157M, led by Aerospace & Aviation. Over CAD 120M in new window business bookings signal strong manufacturing recovery, while 2024 EBITDA is expected at the upper end of guidance.